# Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)

> **NCT04897074** · NA · COMPLETED · sponsor: **Akili Interactive Labs, Inc.** · enrollment: 165 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DEVICE:** AKL-T01

## Key facts

- **NCT ID:** NCT04897074
- **Lead sponsor:** Akili Interactive Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-29
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897074, "Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04897074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
